Glenmark Chief On ‘Big Shift’ In Revenue By Region, Liraglutide India Outlook

Momentum in Europe may see the region’s contribution to Glenmark’s revenues become almost as big as the US business, currently dented by multiple challenges. The firm also outlines how things are poised in India for its biosimilar to Novo Nordisk’s Victoza.